Study of Temzolomide and Gleevec in Advanced Melanoma
Status:
Terminated
Trial end date:
2011-03-09
Target enrollment:
Participant gender:
Summary
This study has been designed to evaluate the side effects of Gleevec when given in
combination with Temzolomide; and to learn more about how these drugs work in the body and
whether this combination is useful in treating patients with melanoma.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Abramson Cancer Center of the University of Pennsylvania